Discover
DWTX
Dogwood Therapeutics, Inc.
1.40
1 x 1.36
1 x 1.47
bid
ask
+
0.00
0.00%
09:17 AM
timesize
| Ytd | -66.35% | |
| 1y | -70.89% |
1.43
day range
1.43
1.28
52 week range
9.50
| Open | 1.43 | Prev Close | 1.40 | Low | 1.43 | High | 1.43 | Mkt Cap | 2.68M |
| Vol | 159.00 | Avg Vol | 91.87K | EPS | -10.60 | P/E | -0.13 | Forward P/E | -0.43 |
| Beta | 1.70 | Short Ratio | 0.42 | Inst. Own | 3.24% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 1.59 | 200-d Avg | 3.36 | 1yr Est | 13.83 |
| Income Statement | |||
| Operating Expenses | 5.08M | ||
| Research and Development Expense | 2.67M | ||
| Selling, General and Administrative Expense | 2.41M | ||
| Operating Income | -5.08M | ||
| Interest Expense | -77.35K | ||
| Income Tax Expense | 1.19K | ||
| Net Income | -4.99M | ||
| Net Income Common Stock | -4.99M | ||
| Net Income Common Stock (USD) | -4.99M | ||
| Consolidated Income | -4.99M | ||
| Earnings per Basic Share | -0.15 | ||
| Earnings per Basic Share (USD) | -0.15 | ||
| Earnings per Diluted Share | -0.15 | ||
| Earning Before Interest & Taxes (EBIT) | -5.06M | ||
| Earning Before Interest & Taxes (USD) | -5.06M | ||
| Weighted Average Shares | 33.54M | ||
| Weighted Average Shares Diluted | 33.54M | ||
| Balance Sheet | |||
| Cash and Equivalents | 13.23M | ||
| Cash and Equivalents (USD) | 13.23M | ||
| Current Assets | 15.00M | ||
| Property, Plant & Equipment Net | 159.29K | ||
| Total Assets | 95.21M | ||
| Total Debt | 87.62K | ||
| Current Liabilities | 2.56M | ||
| Debt Non-Current | 87.62K | ||
| Total Liabilities | 14.58M | ||
| Accumulated Retained Earnings (Deficit) | -113.06M | ||
| Accumulated Other Comprehensive Income | -1.72M | ||
| Shareholders Equity | 80.62M | ||
| Shareholders Equity (USD) | 80.62M | ||
| Assets Non-Current | 80.20M | ||
| Total Debt (USD) | 87.62K | ||
| Deferred Revenue | 38.29K | ||
| Goodwill and Intangible Assets | 80.03M | ||
| Liabilities Non-Current | 12.02M | ||
| Trade and Non-Trade Payables | 144.40K | ||
| Tax Liabilities | 11.91M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 16.84K | ||
| Net Cash Flow from Financing | 11.29M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.70M | ||
| Issuance (Purchase) of Equity Shares | 11.40M | ||
| Net Cash Flow from Operations | -4.59M | ||
| Effect of Exchange Rate Changes on Cash | -1.04K | ||
| Share Based Compensation | 449.42K | ||